Opus Genetics IRD Peer Comparison

NASDAQ IRD
$4.59 -0.01 (-0.11%)
As of: Sep 4, 2026 · 12:49 PM EDT
Peer Comparison

300 Comparable Companies

Industry Gene and Cell Therapy

Opus Genetics, Inc. (IRD) is the 148th largest of 300 Gene and Cell Therapy companies by market capitalisation, at 432.54 Mn, behind Inhibikase Therapeutics, Inc. at 434.68 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 KRYS Krystal Biotech, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 10.60 Bn 43.89 24.06 9.75 Bn
2 CRSP CRISPR Therapeutics AG primary H-03 Pharmaceuticals and Biotechnology HG-01 5.36 Bn -11.09 400.52 5.36 Bn
3 LEGN Legend Biotech Corp primary H-03 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -191.00 3.16 3.06 Bn
4 IOVA Iovance Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 3.98 Bn -19.04 12.25 3.68 Bn
5 BEAM Beam Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 3.10 Bn -36.26 19.85 3.10 Bn
6 QURE uniQure N.V. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -14.99 157.95 2.95 Bn
7 PGEN Precigen, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.55 Bn -7.56 29.71 2.55 Bn
8 SRPT Sarepta Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -17.04 1.18 1.54 Bn
9 MESO Mesoblast Ltd primary H-03 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -38.60 18.46 2.13 Bn
10 VCEL Vericel Corp primary H-03 Pharmaceuticals and Biotechnology HG-01 2.06 Bn 82.17 6.73 1.90 Bn
11 TSHA Taysha Gene Therapies, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.02 Bn -13.50 368.37 2.02 Bn
12 NTLA Intellia Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -4.27 28.68 1.71 Bn
13 SLDB Solid Biosciences Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -7.25 — 1.48 Bn
14 MGTX MeiraGTx Holdings plc primary H-03 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 7.65 3.15 1.12 Bn
15 IMTX Immatics N.V. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.15 Bn -4.76 23.59 0.69 Bn
16 SANA Sana Biotechnology, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.15 Bn -5.34 — 1.15 Bn
17 FDMT 4D Molecular Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.05 Bn -5.84 11.37 0.68 Bn
18 CADL Candel Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.96 Bn -14.69 — 0.96 Bn
19 IMMX Immix Biopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.88 Bn -27.85 — 0.88 Bn
20 NGNE Neurogene Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.87 Bn -7.78 — 0.87 Bn
21 ALLO Allogene Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.66 Bn -3.97 141.78 0.66 Bn
22 PRME Prime Medicine, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.66 Bn -3.49 161.21 0.66 Bn
23 AUTL Autolus Therapeutics plc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -2.33 5.33 0.40 Bn
24 BNTC Benitec Biopharma Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -12.61 — 0.58 Bn
25 CAPR Capricor Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -4.35 — 0.55 Bn
26 CABA Cabaletta Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -2.83 — 0.52 Bn
27 KYTX Kyverna Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -3.30 — 0.50 Bn
28 RGNX REGENXBIO Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -2.66 2.49 0.37 Bn
29 OCGN Ocugen, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -5.46 97.61 0.35 Bn
30 ARTV Artiva Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.86 — 0.44 Bn
31 IPSC Century Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -3.99 — 0.18 Bn
32 IRD Opus Genetics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -4.45 43.89 0.34 Bn
33 RCKT Rocket Pharmaceuticals, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -24.89 — 0.43 Bn
34 LXEO Lexeo Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -4.79 — 0.42 Bn
35 PROK Prokidney Corp. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -2.85 465.26 0.38 Bn
36 ABEO Abeona Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -3.12 13.22 0.19 Bn
37 LYEL Lyell Immunopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -1.35 12,343.98 0.33 Bn
38 CLLS Cellectis S.A. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -9.71 5.47 0.16 Bn
39 FATE Fate Therapeutics Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -2.36 45.54 0.30 Bn
40 EDIT Editas Medicine, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.28 Bn — — 0.13 Bn
41 NWBO Northwest Biotherapeutics Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -7.14 127.74 0.28 Bn
42 LCTX Lineage Cell Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -11.91 20.88 0.22 Bn
43 RNAC Cartesian Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -2.48 182.75 0.27 Bn
44 TARA Protara Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -3.42 — 0.24 Bn
45 NKTX Nkarta, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.49 — 0.21 Bn
46 VYGR Voyager Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.50 5.98 0.09 Bn
47 DTIL Precision Biosciences Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -5.69 4.29 0.11 Bn
48 CRBU Caribou Biosciences, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -1.44 15.75 0.05 Bn
49 ZSQR Z Squared Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -7.96 54.89 0.14 Bn
50 TNYA Tenaya Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -1.45 111.83 0.15 Bn
51 HUMA Humacyte, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -1.18 66.49 0.14 Bn
52 ATRA Atara Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -5.91 22.45 0.12 Bn
53 ENGN enGene Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -1.01 — 0.13 Bn
54 ACET Adicet Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -1.04 — -0.02 Bn
55 ANIX Anixa Biosciences Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.96 — 0.10 Bn
56 INMB Inmune Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.10 — 0.04 Bn
57 APTN Adaptin Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -10.22 — 0.06 Bn
58 INKT MiNK Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -4.88 — 0.06 Bn
59 TCRX TScan Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.43 7.20 0.05 Bn
60 SGMOQ Sangamo Therapeutics, Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.36 1.13 0.02 Bn
61 MGX Metagenomi Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.47 2.02 0.04 Bn
62 CELU Celularity Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.47 1.63 0.04 Bn
63 ESLA Estrella Immunopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -4.09 — 0.03 Bn
64 TVGN Tevogen Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.20 — 0.03 Bn
65 MRKR Marker Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.36 — 0.01 Bn
66 INAB In8Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.27 — 0.02 Bn
67 LGVN Longeveron Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.91 18.00 0.01 Bn
68 GNTA Genenta Science S.p.A. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -3.83 — -0.01 Bn
69 PASG Passage BIO, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.39 — 0.02 Bn
70 PLUR Pluri Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.00 10.00 0.00 Bn
71 ADIA Adia Nutrition, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -75.51 69.62 0.01 Bn
72 FBLG FibroBiologics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.70 — 0.01 Bn
73 SNTI Senti Biosciences Holdings, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.16 618.31 0.01 Bn
74 GDTC CytoMed Therapeutics Ltd primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.36 41.92 0.01 Bn
75 ZEOX Zeo ScientifiX, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -2.21 1.34 0.01 Bn
76 LNAI Lunai Bioworks Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.05 84.35 0.00 Bn
77 TPST Tempest Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.27 — 0.00 Bn
78 PMCB PharmaCyte Biotech, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.18 — 0.00 Bn
79 MBIO Mustang Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.20 — 0.00 Bn
80 ISCO International Stem Cell CORP primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -9.66 0.32 0.00 Bn
81 CLDI Calidi Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.08 — 0.00 Bn
82 GNPX Genprex, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -0.01 Bn
83 CELZ Creative Medical Technology Holdings, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.21 519.79 0.00 Bn
84 RMTG Regenerative Medical Technology Group Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.11 0.12 0.00 Bn
85 BRTX BioRestorative Therapies, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.18 0.00 Bn
86 ERNAW Ernexa Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — 0.00 Bn
87 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 665.45 Bn 31.63 6.80 644.70 Bn
88 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 455.00 Bn 72.04 7.07 448.44 Bn
89 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 371.85 Bn 117.34 5.59 364.71 Bn
90 NVS Novartis Ag secondary H-01 Pharmaceuticals and Biotechnology HG-01 310.65 Bn 13.81 4.52 302.96 Bn
91 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.88 Bn -64.90 6.17 184.70 Bn
92 PFE Pfizer Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 163.02 Bn 37.32 2.56 151.32 Bn
93 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 139.76 Bn 31.73 11.10 131.91 Bn
94 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 53.92 Bn 11.57 1.01 46.54 Bn
95 RVMD Revolution Medicines, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 44.06 Bn -24.92 — 44.06 Bn
96 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.92 Bn 61.66 2.48 39.26 Bn
97 ONC BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 40.08 Bn 61.13 6.54 34.98 Bn
98 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 34.92 Bn 29.32 3.25 33.47 Bn
99 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 31.22 Bn 15.22 1.47 29.11 Bn
100 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.49 Bn -31.40 24.16 26.33 Bn
101 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.59 Bn 15.87 4.40 21.06 Bn
102 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 24.81 Bn -16.71 2,270.94 24.81 Bn
103 UTHR UNITED THERAPEUTICS Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 20.92 Bn 15.96 6.63 18.25 Bn
104 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.79 Bn -48.19 1.34 18.91 Bn
105 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 22.41 4.69 15.42 Bn
106 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.63 Bn 16.61 3.40 14.01 Bn
107 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.82 Bn 17.22 6.09 13.98 Bn
108 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.53 Bn 40.80 4.14 13.92 Bn
109 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.86 Bn 176.29 3.78 11.99 Bn
110 CORT Corcept Therapeutics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 11.61 Bn 214.13 13.97 11.30 Bn
111 KYMR Kymera Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 11.48 Bn -38.33 109.36 10.79 Bn
112 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.73 Bn -69.82 13.82 10.41 Bn
113 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.42 Bn -66.16 17.00 10.31 Bn
114 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.31 Bn -54.81 — 10.31 Bn
115 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.27 Bn -26.92 — 9.51 Bn
116 NUVL Nuvalent, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
117 CYTK Cytokinetics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 9.59 Bn -13.07 141.69 8.42 Bn
118 CRNX Crinetics Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
119 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.53 Bn -8.59 51.43 8.17 Bn
120 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.95 Bn 17.99 9.94 7.27 Bn
121 ALKS Alkermes plc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 7.78 Bn 117.60 4.66 7.12 Bn
122 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.68 Bn -745.97 4,799.49 6.68 Bn
123 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.48 Bn -39.78 1.22 6.11 Bn
124 BLTE Belite Bio, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.27 Bn -81.39 — 6.27 Bn
125 TVTX Travere Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.15 Bn -141.45 10.40 6.15 Bn
126 LQDA Liquidia Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.14 Bn 44.28 13.61 5.85 Bn
127 AMRN Amarin Corp Plc\Uk secondary H-01 Pharmaceuticals and Biotechnology HG-01 5.69 Bn -209.65 30.53 5.37 Bn
128 AMRX Amneal Pharmaceuticals, Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 5.62 Bn 26.09 1.80 5.49 Bn
129 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.03 Bn -17.52 — 5.03 Bn
130 ACAD Acadia Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.80 Bn 12.61 4.21 3.84 Bn
131 EWTX Edgewise Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.56 Bn -23.11 — 4.56 Bn
132 DFTX Definium Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.21 Bn -11.89 — 4.21 Bn
133 INDV Indivior Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.17 Bn 11.75 3.13 3.95 Bn
134 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.17 Bn -8.15 1,156.94 4.17 Bn
135 MANE Veradermics, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.00 Bn -46.46 — 4.00 Bn
136 ELVN Enliven Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.93 Bn -46.69 — 3.93 Bn
137 CPRX CATALYST PHARMACEUTICALS, INC. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
138 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.73 Bn -8.11 31.90 3.03 Bn
139 TARS Tarsus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.67 Bn -78.17 6.05 3.22 Bn
140 OGN Organon & Co. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.62 Bn 17.31 0.59 2.49 Bn
141 NAMS NewAmsterdam Pharma Co N.V. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.12 Bn -12.01 437.80 3.12 Bn
142 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.05 Bn -11.29 593.06 2.53 Bn
143 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.89 Bn -15.38 6.44 2.19 Bn
144 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.85 Bn -8.35 77.53 2.41 Bn
145 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.66 Bn -82.06 — 2.66 Bn
146 TRVI Trevi Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.65 Bn -62.90 — 2.65 Bn
147 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.65 Bn 4.62 0.06 -3.15 Bn
148 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.55 Bn -29.98 3.24 2.18 Bn
149 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.55 Bn -21.53 1.95 2.46 Bn
150 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.53 Bn -6.57 4.72 2.17 Bn
151 BHC Bausch Health Companies Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 2.49 Bn -2.28 0.23 0.65 Bn
152 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn 13.68 2.54 1.63 Bn
153 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.36 Bn -21.84 13.90 2.36 Bn
154 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.35 Bn -4.01 — 2.09 Bn
155 MLYS Mineralys Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -6.68 — 2.34 Bn
156 PVLA Palvella Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.24 Bn -42.18 — 1.92 Bn
157 FMS Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 2.21 Bn 1.85 0.08 0.38 Bn
158 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 6.68 6.73 1.65 Bn
159 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -5.01 2,081.76 2.08 Bn
160 LKFT Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.88 Bn 0.01 1.63 1.88 Bn
161 ETON Eton Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.61 Bn 168.97 16.09 1.59 Bn
162 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.61 Bn -3.49 2.25 1.32 Bn
163 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -9.11 20.12 1.29 Bn
164 INVA Innoviva, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.56 Bn 7.94 3.03 0.98 Bn
165 ANIP Ani Pharmaceuticals Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 1.51 Bn 14.00 1.54 1.15 Bn
166 LBRX Lb Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -24.36 — 1.47 Bn
167 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -8.99 — 1.47 Bn
168 XERS Xeris Biopharma Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -84.88 4.34 1.34 Bn
169 HROW Harrow, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -42.74 5.19 1.35 Bn
170 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 80.34 35.69 1.37 Bn
171 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -28.03 — 1.12 Bn
172 OPK Opko Health, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -32.11 2.07 0.92 Bn
173 KURA Kura Oncology, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -4.88 15.05 1.16 Bn
174 OLMA Olema Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.12 Bn -5.49 — 1.12 Bn
175 PCRX Pacira BioSciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.05 Bn 71.58 1.40 0.80 Bn
176 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -72.51 — 0.95 Bn
177 LXRX Lexicon Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -15.55 23.59 0.79 Bn
178 SGP SpyGlass Pharma, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.96 Bn -48.80 — 0.96 Bn
179 DSGN Design Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -11.76 — 0.74 Bn
180 IVA Inventiva S.A. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 9.70 179.22 0.89 Bn
181 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn -10.92 105.78 0.87 Bn
182 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -6.82 8.99 0.65 Bn
183 COLL Collegium Pharmaceutical, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 16.41 0.97 0.64 Bn
184 PHAT Phathom Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -7.65 3.13 0.57 Bn
185 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn 12.73 5.45 0.52 Bn
186 AQST Aquestive Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -8.64 12.50 0.68 Bn
187 GYRE Gyre Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -36.40 5.63 0.61 Bn
188 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.66 Bn 5.28 1.77 0.41 Bn
189 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -366,569.25 — 0.35 Bn
190 MPLT MapLight Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -3.10 — 0.63 Bn
191 EOLS Evolus, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -17.57 1.91 0.56 Bn
192 NVCT Nuvectis Pharma, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -19.43 — 0.59 Bn
193 DCTH Delcath Systems, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.59 Bn 1,187.19 6.15 0.49 Bn
194 SPRY ARS Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -2.53 4.79 0.42 Bn
195 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -15.96 347.86 0.43 Bn
196 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -7.94 23.87 0.25 Bn
197 XFOR X4 Pharmaceuticals, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -5.71 32.49 0.32 Bn
198 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -10.27 78.36 0.26 Bn
199 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.83 — 0.45 Bn
200 PALI Palisade Bio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -12.61 889.92 0.32 Bn
201 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.65 44.01 0.24 Bn
202 IKT Inhibikase Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -6.64 — 0.28 Bn
203 VTVT vTv Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -87.73 11.33 0.42 Bn
204 ACHV Achieve Life Sciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.37 Bn — — 0.37 Bn
205 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 3.72 2.57 0.34 Bn
206 VNDA Vanda Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.18 1.50 0.15 Bn
207 EBS Emergent BioSolutions Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.82 0.42 0.18 Bn
208 SION Sionna Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.26 — 0.32 Bn
209 IMRX Immuneering Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -5.39 — 0.32 Bn
210 SWKHL SWK Holdings Corp secondary F-06 Lending and Credit FG-02 0.31 Bn -332.50 7.47 0.27 Bn
211 TTRX Turn Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -39.20 — 0.30 Bn
212 FULC Fulcrum Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -3.28 — 0.29 Bn
213 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -3.20 20.26 0.11 Bn
214 ZNTL Zentalis Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -2.01 — 0.28 Bn
215 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.92 1.21 0.11 Bn
216 SIGA Siga Technologies Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn — — 0.08 Bn
217 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.14 — 0.22 Bn
218 NERV Minerva Neurosciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -33.70 — 0.22 Bn
219 TNXP Tonix Pharmaceuticals Holding Corp. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.36 7.47 0.22 Bn
220 DERM Journey Medical Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -59.30 3.18 0.19 Bn
221 ACOG Alpha Cognition Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.50 15.37 0.16 Bn
222 SLGL Sol-Gel Technologies Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.52 108.21 0.15 Bn
223 MCUJF Medicure Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -36.51 8.32 0.19 Bn
224 CRDL Cardiol Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -7.18 — 0.17 Bn
225 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.02 0.00 -10.88 Bn
226 LENZ LENZ Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.41 8.50 0.18 Bn
227 LONA LeonaBio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.47 — 0.13 Bn
228 MENS Jyong Biotech Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -44.35 — 0.17 Bn
229 IFRX InflaRx N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -3.71 1,899.21 -0.03 Bn
230 BMEA Biomea Fusion, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.55 — 0.14 Bn
231 SPRB Spruce Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.89 — 0.14 Bn
232 HURA TuHURA Biosciences, Inc./NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.44 — 0.14 Bn
233 VANI Vivani Medical, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.73 — 0.11 Bn
234 NTHI Neonc Technologies Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.83 — 0.13 Bn
235 AARD Aardvark Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.70 — 0.04 Bn
236 VRCA Verrica Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -3.67 3.81 0.10 Bn
237 GUTS Fractyl Health, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.11 Bn -0.86 — 0.11 Bn
238 CPIX Cumberland Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.30 3.21 0.10 Bn
239 PLYX Polaryx Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.64 — 0.08 Bn
240 CGTX Cognition Therapeutics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.55 — 0.09 Bn
241 RGC Regencell Bioscience Holdings Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
242 PYPD PolyPid Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 2.78 — 0.08 Bn
243 FBIO Fortress Biotech, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 10.41 1.26 -0.11 Bn
244 PTHS Pelthos Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -0.77 1.60 0.06 Bn
245 TENX Tenax Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.29 — 0.08 Bn
246 AIFC AI Financial Corp secondary T-54 Fintech TG-09 0.08 Bn -0.09 3.90 0.07 Bn
247 MNOV Medicinova Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -6.83 89.81 0.08 Bn
248 PLRX Pliant Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -0.75 — 0.07 Bn
249 PMVP PMV Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.14 — -0.01 Bn
250 CING Cingulate Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -3.11 — 0.07 Bn
251 BOLD Boundless Bio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.01 — 0.06 Bn
252 VERU Veru Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 124.74 — 0.04 Bn
253 GOSS Gossamer Bio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.33 1.05 0.00 Bn
254 KPTI Karyopharm Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.27 0.35 0.05 Bn
255 ANVS Annovis Bio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.07 — 0.05 Bn
256 PTN Palatin Technologies Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.92 3.86 0.05 Bn
257 CLNN Clene Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.41 225.14 0.05 Bn
258 SER Serina Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.52 330.85 0.02 Bn
259 APRE Aprea Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.43 — 0.04 Bn
260 IXHL Incannex Healthcare Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.84 — 0.04 Bn
261 APLM Apollomics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.67 4.72 0.04 Bn
262 SCLX Scilex Holding Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.09 1.24 -0.07 Bn
263 GRCE Grace Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.82 — 0.04 Bn
264 ACTU Actuate Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.65 — 0.03 Bn
265 CPHI China Pharma Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -7.56 8.64 0.03 Bn
266 UG United Guardian Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 14.60 2.95 0.02 Bn
267 ATNM Actinium Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 2.85 0.92 0.03 Bn
268 BETRF BetterLife Pharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.82 — 0.03 Bn
269 KAPA Kairos Pharma, LTD. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.68 0.35 0.03 Bn
270 NSRX Nasus Pharma Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.64 — 0.03 Bn
271 YARW Yarrow Bioscience, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.31 54.52 0.00 Bn
272 CRVO CervoMed Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.87 79.47 0.03 Bn
273 BYSI BeyondSpring Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.12 — 0.03 Bn
274 TXMD TherapeuticsMD, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -138.89 7.86 0.02 Bn
275 AYTU Aytu Biopharma, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.75 0.41 0.00 Bn
276 ALLR Allarity Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.88 910.09 0.02 Bn
277 ATOS Atossa Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.74 — 0.02 Bn
278 BFRI Biofrontera Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.26 0.44 0.02 Bn
279 MIRA Mira Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.55 — 0.01 Bn
280 TVRD Tvardi Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.66 — 0.02 Bn
281 KPRX Kiora Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.46 — 0.02 Bn
282 MDBH MDB Capital Holdings, LLC secondary F-17 Capital Markets FG-05 0.02 Bn -1.29 — 0.01 Bn
283 CTXR Citius Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.34 2.20 0.02 Bn
284 INTI Inhibitor Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.72 — 0.02 Bn
285 QCLS Q/C Technologies, Inc. secondary T-01 Semiconductors TG-01 0.02 Bn -2.05 — 0.02 Bn
286 RKTO Rocket One Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.06 — 0.01 Bn
287 ANEB Anebulo Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.37 — 0.01 Bn
288 CURX Curanex Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.01 — 0.00 Bn
289 CALC CalciMedica, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 -8.75 -0.01 Bn
290 RVPH Reviva Pharmaceuticals Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.82 — 0.01 Bn
291 ADXN Addex Therapeutics Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.05 — 0.01 Bn
292 ACXP Acurx Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.80 — 0.01 Bn
293 TRAW Traws Pharma, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 — 0.00 Bn
294 PCSA Processa Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.42 — 0.01 Bn
295 INM InMed Pharmaceuticals Inc. secondary M-02 Chemicals MG-01 0.01 Bn -0.69 — 0.00 Bn
296 PULM Pulmatrix, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.31 — 0.01 Bn
297 TCRT Alaunos Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.99 1,345.54 0.00 Bn
298 CVKD Cadrenal Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.30 — 0.00 Bn
299 BICX BioCorRx Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.64 6.70 0.00 Bn
300 CASIF CASI Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn